Childhood Absence Epilepsy

Childhood Absence Epilepsy - most related articles:

- Ethosuximide is preferred for childhood epilepsy - 9.9
- Premature birth increases epilepsy risk later in life - 6.2
- Early treatment stops epilepsy seizures - 6.2
- Pay more attention to epilepsy, affects millions of people - 5.8
- Epilepsy drug topiramate during pregnancy raises birth defects risk - 5.7
- Epilepsy surgery has good effect - 5.2
- Patterns of medication nonadherence in epilepsy children linked to socioeconomic status - 5.1
- Epilepsy drug valproate during pregnancy lowers child's IQ - 4.9
- Sickness absence can predict employee mortality - 4.6
- Oxcarbazepine doesn't help prevent migraine after all - 4.4

Childhood Absence Epilepsy articles

Ethosuximide is preferred for childhood epilepsy
The first comprehensive comparative effectiveness clinical trial of three widely used anti-seizure drugs for childhood absence epilepsy ? the most common form of epilepsy in kids ? has established an evidence-based approach for initial drug therapy.

1 Childhood Absence Epilepsy articles listed above.


Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.
Subscribe: rss | email

Top sections:
Health (188)
Breast cancer (168)
Healthcare (134)
HIV (129)
Obesity (126)
Pregnancy (114)
Diabetes (101)
Swine Flu (97)
Prostate Cancer (86)
Heart disease (84)
Smoking (81)
Alzheimer's Disease (79)
Cancer (75)
Depression (61)
Autism (52)


List health news, Health organizations, Health news world, Glossary     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2014 HealthNewstrack.com
0.36